Institutional Ownership
Neurosense Therapeutics Ltd
CUSIP M74240108ORDINARY SHARESQ1 2026
Institutional Holders
13
13F filers
Shares Held
379.7K
Aggregate institutional
Institutional Value
$286.7K
Q1 2026
Net New Holders
+0
3 new · 3 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions3
Increased1
Decreased3
Sold out3
Institutional Holders
13 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Yorkville Advisors Global, LP | 78.0K | $58.9K | −22.0K | Reduced |
| 2 | Independent Advisor Alliance | 50.0K | $37.8K | +50.0K | New |
| 3 | Ubs Group AG | 49.1K | $37.1K | +18.2K | Added |
| 4 | Two Sigma Investments, LP | 44.4K | $33.6K | −7.1K | Reduced |
| 5 | Meitav Investment House Ltd | 40.0K | $30.2K | 0 | Held |
| 6 | Jane Street Group, LLC | 28.7K | $21.6K | +28.7K | New |
| 7 | Commonwealth Equity Services, LLC | 22.8K | $17.2K | 0 | Held |
| 8 | Pnc Financial Services Group, Inc. | 21.1K | $16.0K | +21.1K | New |
| 9 | Pathstone Holdings, LLC | 16.5K | $12.5K | 0 | Held |
| 10 | Geode Capital Management, LLC | 15.9K | $12.0K | 0 | Held |
3 more institutional holders on Premium
See every fund holding Neurosense Therapeutics Ltd, with full quarter-over-quarter share changes.
Unlock all holders